Europe Aortic Stent Graft Market Report and Forecast 2024-2032

Europe Aortic Stent Graft Market Outlook

The global aortic stent graft market size was valued at USD 3.1 billion in 2023, with Europe holding a significant market share. It is driven by the continuous advancements in stent graft material and design. The global market is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, with the values likely to attain USD 5.2 billion by 2032.

Key Takeaways

• The prevalence of abdominal aortic aneurysms (AAAs) is reported to fall in a range between 4% to 7.2% in Western populations. The high prevalence rate of aortic aneurysms is likely to boost demand for minimally invasive treatment options such as aortic stent grafts in coming years.

• Positive clinical outcomes indicate stent graft systems as an effective intervention, influencing the adoption rate and fuelling the Europe aortic stent graft market demand. In April 2023, Medtronic plc revealed positive results from its 10-year post-market ENGAGE registry for its Endurant stent graft system in treating patients with abdominal aortic aneurysms.

• The market is witnessing increased screening initiatives by the government that lead to high detection and diagnosis rates of aortic aneurysms, augmenting the demand for effective medical interventions including aortic stent grafts. One such abdominal aortic aneurysm screening program is available for men aged 65 or more in England.

Europe Aortic Stent Graft Market Analysis

An aortic stent graft is primarily utilized to treat abdominal aortic aneurysms (AAAs) and thoracic aortic aneurysms (TAAs). The stent graft is a tube that consists of a fabric supported by a metal mesh. It can help to seal the artery above and below the aneurysm (a weak spot in an artery) and prevent its rupture. The continuous innovation in stent graft materials and design has improved its flexibility and durability. Such advancements also contribute significantly to the Europe aortic stent graft market growth as they enable reduced procedural complications and better patient outcomes.

In Europe, the rising geriatric population coupled with the increased prevalence of risk factors such as smoking and hypertension, is leading to a high prevalence rate of aortic aneurysms. Recent data suggests that the prevalence of abdominal aortic aneurysms (AAAs) falls in a range between 4% to 7.2% in Western populations. With the increasing patient population having such aneurysms, the demand for minimally invasive treatment options, such as aortic stent grafts is likely to rise, which is expected to positively influence the Europe aortic stent graft market share in the forecast period.

In April 2023, Medtronic plc, revealed positive results from its 10-year post-market ENGAGE registry at the 2023 Charing Cross Symposium in London. The results were shared for its Endurant stent graft system in treating patients with abdominal aortic aneurysm. The study involving about 400 patients from 49 sites in 21 countries showed 94.7% freedom from aneurysm-related mortality and 64.1% decreased sac diameter at 10 years. Such real-world data establishes positive clinical outcomes, fuelling the adoption rates of aortic stent grafts and consequently driving market demand.

One of the major Europe aortic stent graft market trends is the increased screening initiatives by the government that lead to high detection and diagnosis rates of aortic aneurysms. Such government-sponsored screening programs not only heighten public awareness surrounding aneurysms but also augment the demand for effective treatments including aortic stent grafts. In England, one such abdominal aortic aneurysm screening program is available for men aged 65 or more, as they have the highest risk of having the condition. The improved access to screening services is poised to propel market growth in the region.

Europe Aortic Stent Graft Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Europe Aortic Stent Graft Market: Competitor Landscape

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Cook Medical, Inc.

• W.L. Gore & Associates

• MicroPort Scientific Corporation Inc.

• Medtronic Plc.

• Lombard Medical, Inc.

• Endologix, Inc.

• Terumo Corporation Inc.

• Cardinal Health Inc.

• Becton, Dickinson and Company

• CryoLife Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report